Table 8.
Y | Treatment | Intercept | Variable X | r | R2 | RSD 1 | p (Lineal) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Plasma Vitamin E (x) | |||||||||||||
Plasma MDA | PSB-0 | 2.02 | ± | 0.17 | −0.64 | a | ± | 0.15 | −0.5255 | 0.2572 | 0.26 | 0.0001 | |
Plasma MDA | PSB-2 | 2.08 | ± | 0.26 | −0.68 | a | ± | 0.23 | −0.5099 | 0.2600 | 0.30 | 0.0078 | |
Plasma MDA | OLG-mix-0 | 2.33 | ± | 0.22 | −0.91 | a | ± | 0.20 | −0.6846 | 0.4686 | 0.25 | 0.0001 | |
Plasma MDA | OLG-mix 2 | 2.05 | ± | 0.23 | −0.60 | b | ± | 0.20 | −0.5511 | 0.3037 | 0.21 | 0.0064 | |
Plasma SOD (x) | |||||||||||||
Muscle MDA | PSB-0 | 3.45 | ± | 0.32 | −0.74 | a | ± | 0.32 | −0.4762 | 0.2268 | 0.44 | 0.0216 | |
Muscle MDA | PSB-2 | 2.63 | ± | 0.23 | −0.48 | b | ± | 0.18 | −0.5102 | 0.2603 | 0.36 | 0.0129 | |
Muscle MDA | OLG-mix 0 | 3.40 | ± | 0.39 | −0.89 | a | ± | 0.37 | −0.4542 | 0.2063 | 0.58 | 0.0258 | |
Muscle MDA | OLG-mix 2 | 2.67 | ± | 0.24 | −0.40 | b | ± | 0.20 | −0.3752 | 0.1407 | 0.41 | 0.0500 |
1 SD: standard deviation (n = 30 replicates for each main effects, n = 15 replicates for the interaction). p: differences were statistically significant when p < 0.05; a, b. Letter with different superscript were statistically significant.